Trulicity studies involving other diabetes drugs revealed that between 50% and 67% of adult patients with an average starting A1C level between 8% and 8.6% saw A1C levels drop below 7% with the use of ...
Eversense 365 cleared in the U.S. as an integrated continuous glucose monitoring (iCGM) system for people with diabetes With a single sensor, the Eversense 365 system provides one year of use, versus ...